Table 2.
Data from Microarray Analysis (ND vs. UDM)
| ND vs. UDM(Pre−CP/Rep) | ND vs. UDM (Post−CP/Rep) | |||
|---|---|---|---|---|
| −Log (P) | Fold Change | −Log (P) | Fold Change | |
| CD34 | 1.4276 | −2.1159 | 1.353516 | −1.48858 |
| CD36 | 0.2626 | −0.25267 | 0.351938 | 0.081563 |
| CD47 | 0.5883 | −0.576 | 0.52975 | −0.224 |
| CD93 | 0.54005 | 0.0617 | 0.422063 | −0.12919 |
| CD151 | 1.704313 | −2.39938 | 1.303412 | −1.38512 |
| CD160 | 0.668 | −0.19964 | 0.447219 | 0.118125 |
| CDH1 | 0.643667 | −0.0658 | 0.526406 | −0.17144 |
| CDH2 | 1.0502 | −1.3318 | 0.365879 | −0.356 |
| CDH4 | 0.978333 | −0.5566 | 0.405063 | 0.22025 |
| CDH5 | 1.398571 | −1.25614 | 0.79 | −0.38873 |
| CDH12 | 0.843632 | −0.38221 | 0.489375 | −0.20944 |
| CDH13 | 0.682818 | −0.3597 | 0.658646 | 0.148854 |
| CEACAM1 (includes others) | 0.594692 | −0.00969 | 0.428625 | 0.149469 |
| CLDN3 | 0.701545 | −0.23564 | 0.39025 | −0.16294 |
| ENG | 1.033917 | −1.53908 | 0.802688 | −0.96944 |
| EPOR | 0.903237 | −0.67078 | 0.77463 | −0.66859 |
| ITGA1 | 1.599308 | 1.025769 | 1.029875 | 0.629094 |
| ITGA2 | 0.577 | −0.09233 | 0.440724 | −0.00634 |
| ITGA5 | 1.1321 | −1.1905 | 1.056857 | −0.11514 |
| ITGA6 | 0.595042 | 0.158042 | 0.742868 | 0.387755 |
| ITGA9 | 0.74672 | −0.3092 | 0.852154 | −0.27942 |
| ITGAV | 0.556743 | −0.32971 | 0.490837 | −0.31623 |
| ITGB1 | 0.759484 | −0.50865 | 0.753207 | −0.14697 |
| ITGB2 | 0.827176 | −0.73229 | 0.575333 | −0.60953 |
| ITGB3 | 0.645957 | 0.146085 | 0.552762 | 0.002405 |
| ITGB4 | 0.67125 | −0.59822 | 0.697864 | −0.39182 |
| ITGB5 | 0.696662 | −0.607 | 0.716844 | −0.20225 |
| ICAM1 | 0.696661538 | −0.607 | 0.624375 | 0.717375 |
| ICAM2 | 0.749285714 | −0.814816327 | 1.012067 | −0.12296 |
| ILK | 1.0824375 | −1.3874375 | 1.247563 | −0.50819 |
| JAM3 | 0.977529412 | −1.140588235 | 1.02568 | −0.52375 |
| LGALS1 | 0.776368421 | −1.588947368 | 0.912467 | 0.415067 |
| LGALS3 | 0.776368421 | −1.588947368 | 0.851767 | −0.61053 |
| MCAM | 0.590533333 | −0.137866667 | 0.969455 | −0.45009 |
| MFGE8 | 1.33275 | −1.7251875 | 1.997267 | −0.76967 |
| NRCAM | 0.7299375 | −0.134395833 | 0.600314 | −0.07986 |
| OLR1 | 0.619833333 | −0.004166667 | 0.383125 | 0.056875 |
| PECAM1 | 0.6404375 | −0.656604167 | 0.852804 | −0.49317 |
| PODXL | 1.029466667 | −1.4064 | 0.6714 | −0.6736 |
| PLXDC1 | 0.565571429 | −0.174142857 | 0.413563 | 0.222125 |
| PDPN (includes EG:10630) | 0.762770833 | −0.4220625 | 0.713868 | 0.120711 |
| POSTN | 0.6200625 | −0.8625 | 0.882 | −1.11827 |
| PVRL2 | 0.9055625 | −1.17725 | 1.012583 | −0.91138 |
| PROCR | 0.818625 | −0.70175 | 1.051455 | −0.55291 |
| SELE (includes EG:20339) | 0.675625 | −0.11075 | 0.413563 | 0.222125 |
| SELP | 1.0854375 | −0.852 | 0.6605 | −0.50806 |
| S1PR1 | 0.466375 | −0.293375 | 0.8175 | −0.3825 |
| S1PR2 | 1.003 | −0.51425 | 1.295111 | −0.49522 |
| STAB1 | 0.9026875 | −1.2669375 | 1.1958 | −0.72327 |
| THBD | 0.496214286 | −0.354428571 | 0.23375 | 0.429813 |
ND: nondiabetics; UDM: uncontrolled diabetics (poorly controlled); CDH1:cadherin 1; CDH2:cadherin 2; CDH4:cadherin 4; CDH5:cadherin 5, CDH12:cadherin 12, CDH13:cadherin 13, CEACAM1: carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); CLDN3:claudin 3; ENG: endoglin; EPOR:erythropoietin receptor; ICAM1: intercellular adhesion molecule 1; ICAM2: intercellular adhesion molecule 2; ITGA1: integrin, alpha 1; ITGA2: integrin, alpha 2; ITGA5: integrin, alpha 5; ITGA6: integrin, alpha 6; ITGA9: integrin, alpha 9; ITGAV:integrin, alpha V; ITGB1: integrin, beta 1; ITGB2: integrin, beta 2; ITGB3: integrin, beta 3; ITGB4: integrin, beta 4; ITGB5: integrin, beta 5; PDPN: podoplanin; Jam3: junctional adhesion molecule 3; ILK: integrin-linked kinase; LGALS1:lectin, galactoside-binding, soluble, 1; LGALS3: lectin, galactoside-binding, soluble, 3; MCAM: melanoma cell adhesion molecule; MFGE8:milk fat globule-EGF factor 8 protein; NRCAM: neuronal cell adhesion molecule; OLR1: oxidized low density lipoprotein (lectin-like) receptor 1; POSTN: periostin, osteoblast specific factor; PECAM1:platelet/endothelial cell adhesion molecule; PODXL: podocalyxin-like; PVRL2: poliovirus receptor-related 2; PLXDC1: plexin domain containing 1; PROCR: protein C receptor, endothelial; SELP: selectin P; SELE: selectin E; S1PR1: sphingosine-1-phosphate receptor 1; S1PR2:sphingosine-1-phosphate receptor 2; STAB1: stabilin 1; THBD: thrombomodulin.